PHASE I-IV INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIAL DATABASES (MPN/CLL/WM/AML)
- Database
- MPN
- CLL
- Waldenström's macroglobulinemia
- AML
- Targeted therapy
- Cell therapy
- Immunotherapy
- Clinical research (TRL 6-8)
FILO's clinical study databases are a unique resource for retrospective studies in the field of acute myeloid leukemia (AML), myelofibrosis, essential thrombocythemia, chronic lymphocytic leukemia (CLL) and Waldenström's macroglobulinemia (WM).
Clinical protocols conducted under FILO’s sponsoring include the use of an eCRF and monitoring procedures to ensure complete and highly annotated data sets.
Description
Scope
Clinical datasets in the field of AML, myelofibrosis, essential thrombocythemia, CLL and MW for retrospective research purposes, such as:
- Analysis of treatment efficacy and safety
- Identification of predictive or prognostic markers
- Identification of patient cohorts for clinical research
Provision of data
- Submission of retrospective study project to FILO
- Project review by FILO's Scientific Advisory Board (LLC-MW or LAM)
Infrastructure
- Data hosted in an eCRF (Quanticsoft webtrial®)
- Project and data managers
Quality assurance
- Data collected in compliance with good clinical practices and GDPR
- Data from clinical trials monitored against source data
Specifications
Data sets
- About 15 clinical studies in AML, representing more than 2,800 patients
- About 20 clinical trials in CLL and WM, representing more than 3,000 patients
- 5 clinical trials in SMP in collaboration with the FIM Group, representing close to 2,000 patients (including 1,700 in a COVID19 observatory)
Type of studies: interventional and non-interventional clinical trials
Phases: I to IV
Terms
- Research project approved by the FILO scientific committee
- License agreement
OPALE entity
French Innovative Leukemia Organization (FILO)
Head of Entity
Contact
Dr. Sandrine PalcyBusiness Development Director
Other offers
NATIONAL CLINICAL RESEARCH NETWORK FOR THE DESIGN, SPONSORING AND CONDUCT OF PHASE I-IV INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIALS (CLL/WM/AML/MPS)
NATIONAL CLINICAL RESEARCH NETWORK FOR THE DESIGN, SPONSORING AND CONDUCT OF PHASE I-IV INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIALS - COLLABORATION (CLL/WM/AML/MPS)
HEMATOLOGICAL MALIGNANCIES BIOBANK (CLL/AML)